Leave Your Message
-
Phone
-
E-mail
-
Whatsapp
-
Wechat
Canada's medical-grade PVC film market represents a critical segment of the country's $264 billion healthcare industry. With an aging population and increasing demand for advanced medical packaging solutions, the Canadian market for pharmaceutical-grade PVC films is projected to grow at a CAGR of 6.2% through 2030. The country's stringent regulatory environment, governed by Health Canada, ensures that only the highest quality materials are used in medical applications, creating opportunities for certified suppliers who meet these exacting standards.
Medical-grade PVC films in Canada must comply with Health Canada's Medical Devices Regulations (MDR) and the Canadian Standards Association (CSA) requirements. These materials are classified under Class I or Class II medical devices, depending on their application. The regulatory framework ensures biocompatibility, sterility maintenance, and chemical resistance - critical factors for pharmaceutical blister packaging, IV bags, blood bags, and medical tubing applications prevalent across Canadian healthcare facilities from Vancouver General Hospital to Toronto's SickKids Hospital.
Canadian manufacturers and suppliers must also adhere to ISO 13485 quality management standards, ensuring consistent production of medical-grade materials. This regulatory rigor has positioned Canada as a trusted source for medical-grade PVC films, with major pharmaceutical companies in Montreal, Toronto, and Vancouver relying on certified suppliers for their packaging needs.
Canadian healthcare institutions are increasingly demanding eco-friendly medical-grade PVC alternatives. The trend toward bio-based plasticizers and recyclable medical packaging has gained momentum, particularly in British Columbia and Ontario, where environmental regulations are strictest. Manufacturers are developing phthalate-free formulations that maintain medical-grade performance while reducing environmental impact - a critical consideration for Canada's commitment to reducing healthcare waste by 30% by 2030.
The integration of smart technologies into medical-grade PVC packaging is revolutionizing pharmaceutical distribution across Canada's vast geography. RFID-enabled PVC blister packs and temperature-sensitive films are being adopted by major pharmacy chains like Shoppers Drug Mart and Jean Coutu to ensure medication integrity during transport across extreme Canadian climates, from the Arctic territories to temperate coastal regions.
The COVID-19 pandemic highlighted Canada's dependence on imported medical supplies, spurring investment in domestic medical-grade PVC film production. Government initiatives, including the Strategic Innovation Fund, have allocated over $350 million to support local manufacturing capacity in Ontario, Quebec, and Alberta. This trend is creating opportunities for suppliers who can establish production facilities that meet Health Canada's stringent quality standards while serving the growing demand from Canadian pharmaceutical manufacturers.
Canadian pharmaceutical companies are demanding PVC films with enhanced barrier properties to protect sensitive medications from moisture, oxygen, and light. This is particularly critical for biologics and specialty pharmaceuticals manufactured in Canada's growing biotech hubs in Montreal, Toronto, and Vancouver. Multi-layer PVC films with advanced coating technologies are becoming the standard for high-value medication packaging, ensuring shelf life extension and regulatory compliance.
Canada's pharmaceutical industry, valued at over $35 billion annually, relies heavily on medical-grade PVC films for blister packaging. Major pharmaceutical manufacturers in Montreal (including Pfizer Canada and GSK) use rigid PVC films for tablet and capsule packaging. The material's excellent thermoformability, clarity, and barrier properties make it ideal for protecting medications distributed across Canada's diverse climate zones, from humid coastal regions to dry prairie provinces.
Canadian hospitals from St. Paul's Hospital in Vancouver to The Ottawa Hospital utilize medical-grade PVC films in various applications: IV bags, blood collection bags, dialysis equipment, and sterile medical device packaging. The material's biocompatibility and sterilization tolerance make it indispensable for healthcare facilities serving Canada's 38 million population. With over 1,200 hospitals nationwide, the demand for certified medical-grade PVC films continues to grow, particularly for single-use medical devices that prevent cross-contamination.
Canada's medical device sector, concentrated in Ontario and Quebec, produces over $14 billion in products annually. Medical-grade PVC films are essential for manufacturing respiratory masks, oxygen delivery systems, and surgical equipment packaging. Companies in Mississauga, Markham, and Laval require PVC films that meet ISO 10993 biocompatibility standards and can withstand various sterilization methods including gamma radiation, ethylene oxide, and steam sterilization.
Canada's vast geography presents unique challenges for pharmaceutical distribution. Medical-grade PVC films with temperature-stable properties are crucial for maintaining medication efficacy during transport across the country's six time zones and extreme temperature variations (-40°C in winter territories to +35°C in summer prairies). Distribution centers in Calgary, Winnipeg, and Halifax rely on high-performance PVC packaging to ensure product integrity throughout the supply chain.
Jiangsu Dahai Plastics Co., Ltd. was founded in 1996, is a professional production of various types of PVC film and printing PVC film technology of private enterprises. We mainly produce super transparent film, ordinary transparent film, toy film, bath film, raincoat film, electrical tape film, cold film, non-stick film, decorative film, PEVA film, particles, tablecloth, shower curtain, urine bag.
The company has more than 20 production lines, more than 450 employees, of which 30% are technical management personnel, and has a sound management system. Covers an area of more than 120,000 square meters, annual output of more than 100,000 tons, annual sales of more than 1 billion. The company continues to introduce advanced production equipment and technology. The product quality reaches the international standard, the company's products not only sell well in the domestic market, but also exported to South America, Southeast Asia, Africa and other places.
Our medical-grade PVC films are specifically engineered to meet Health Canada's stringent requirements, making us an ideal supplier for Canadian pharmaceutical and healthcare industries. With certifications including ISO 13485 and compliance with FDA and European Pharmacopoeia standards, we ensure that our products meet the highest international quality benchmarks required for the Canadian market.
We possess laboratories accredited by China National Commission for Conformity Assessment (CNAS), which are equipped with many kinds of world advanced experimental equipment and physical and chemical testing-analysis instruments. In every experiment, in every test, even the slightest difference can be detected by our machines, which greatly guarantees the quality of our products.
DAHAI continues to invest resources, and we will work with university teams to develop products. Our technical department is constantly learning new technologies and combining them with our own situation, through which our ability to innovate is keeping improving.
For the Canadian market, we ensure all medical-grade PVC films undergo rigorous testing for biocompatibility, extractables and leachables, mechanical properties, and barrier performance. Our quality management system is designed to meet Health Canada's Medical Device Single Audit Program (MDSAP) requirements, ensuring seamless compliance for Canadian importers and distributors.
Contact UsThe total registered capital of several projects under the company group is 40 million dollar, total assets reach 140 million dollar, floor area is more than 120000sqm, with 20 imported environmental protection production lines, with an annual production capacity of 150,000 tons. In year 2018, we achieved sales of 180 million dollar, of which exports earned 10 million US dollars. The products are sold to more than 400 cities in 12 provinces and regions across the country, the market share ranks first among private enterprises in the province, and the products are exported to more than 10 countries and regions. In view of the market development trend and the future development of the company, it is proposed to build an intelligent manufacturing project of new medical materials.
Our commitment to the Canadian market includes establishing distribution partnerships in major cities including Toronto, Montreal, Vancouver, Calgary, and Ottawa. We understand the unique requirements of the Canadian healthcare system and are prepared to support pharmaceutical manufacturers, medical device companies, and healthcare distributors with reliable, compliant medical-grade PVC film solutions.
Make green materials, create a good and healthy life!
To become the domestic polymer material application industry leader, to build a world-class brand!
Independent innovation intelligent future! Team style: people-oriented safety first!
Integrity, pragmatic, efficient, win-win!
Tongzhou Huaming Plastic Co., Ltd. was established.
Tongzhou Huaming Plastics Co., Ltd. was changed to Jiangsu Dahai Plastics Co., LTD.
Nantong Runyang Plastic Co., Ltd. was established.
Dahai Real Estate Development Co., Ltd. was established.
Field E-commerce company is established.
Jiangyin Zhonglian Real Estate company was established.
Jiangyin Huayue Real Estate Development Co., Ltd. was established.
Jiangsu Houbang Industrial Co., LTD. was established, marking our expansion into advanced medical materials.
We import all kinds of testing machines, such as universal testing machines, Agilent GC analyzers, gloss meters and cold-tolerance testing machines. Besides, we establish good cooperation with professional testing companies to meet customer's requirements. All of our products can meet the requirements of EN-71, ASTM-F-963, Model Toxics in Packaging Legislation (CONEG) and RoHS.
For Canadian customers, our certifications ensure compliance with Health Canada regulations and facilitate smooth importation and distribution of medical-grade PVC films across all provinces and territories.
Our dedicated sales and technical teams engage closely with customers to gather detailed specifications, discuss project goals, and identify any unique challenges.
Once the needs are confirmed, we move into the product proofing phase. During this stage, we create prototypes or samples based on the agreed-upon specifications.
After thorough evaluation and refinement, we finalize the sample that both parties agree upon. The confirmed sample serves as the benchmark for all subsequent production runs.
Our make-to-order approach allows us to tailor our production processes to meet individual client needs. Leveraging our flexible manufacturing capabilities.
Upon completion of production, each item undergoes a comprehensive finished inspection. Our quality assurance team employs advanced testing methods.
We actively seek feedback to continuously improve our services and adapt to evolving market demands. Through ongoing partnerships, we aim to be more than just a supplier.
